Image

SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)

Recruiting
19 years of age
Both
Phase N/A

Powered by AI

Overview

To test the effects of home-based care on unplanned hospitalization within 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups.

Description

This study is a cluster, non-randomized controlled trial to test the effects of home-based care on unplanned hospitalization in 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-up. We are recruiting the study participants from 6 institutions, aiming for 396 cancer patients.

Participants for the intervention group will be recruited from Seoul National University Hospital, Chung-ang University Hospital, and Dongguk University Ilsan Hospital. Participants for the control group will be recruited from Kyung Hee University Medical Center, CHA Bundang Medical Center, and Seoul National University Bundang Hospital.

Eligibility

Inclusion Criteria:

        Both the patient and their family caregiver must meet the criteria to be considered for
        this research.
          1. Patient
               1. A person who has an advanced-stage solid cancer diagnosis (ICD-10 code C00-C70);
                  A person who is receiving or planning to receive cancer treatment
               2. A person who meets one of the following conditions
                    1. Has been evaluated as having ECOG performance status 2
                    2. Has been evaluated as having ECOG performance status 1 and is over 70 years
                       of age
               3. A person who wishes to stay at home
               4. A person whose family caregiver resides at home
               5. A person who wishes to participate in the research
          2. Family Caregiver
               1. A family* member of the patient
                  * Family: refers to the patient's spouse (including a common-law partner),
                  descendants and their spouses up to the second degree, siblings and their
                  spouses, and relatives and their spouses up to the eighth degree.
               2. A person who meets one of the following conditions:
                    1. Lives with the patient (patient's household member)
                    2. Does not live with the patient, but visits the patient's home more than
                       three times a week
               3. A person who wants the patient to stay at home
               4. A person who can communicate easily with medical staff
               5. A person who wishes to participate in the research
        Exclusion Criteria:
        If either the patient or the family caregiver meets any one of these criteria, they are
        excluded from the study.
          1. Patient
               1. A person who cannot speak, hear, or read Korean
               2. A person who is judged by a medical doctor to be unable to take part in this
                  research due to extremely poor health
               3. A person residing outside the range that can be visited by the respective medical
                  institution (the conditions for distance are to be specified by each medical
                  institution)*
                  * This condition is not applicable for the control group.
               4. A person who has used hospital- or home-type hospice and palliative care services
               5. A person who is under the age of 19
          2. Family Caregiver
               1. A person who cannot speak, hear, or read Korean
               2. A person who is judged by a medical doctor to be unable to take part in this
                  research due to extremely poor health
               3. A person under the age of 19

Study details

Malignant Neoplasm, Home Care Services, Quality of LIfe, Unplanned Hospitalization

NCT05636384

Seoul National University Hospital

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.